Guidelines: COVID-19 Symptom Eval | 2020 CDC, NIH, WHO Guidance Synthesis
Guideline Resources
COVID-19 Symptom Eval | 2020 CDC, NIH, WHO Guidance Synthesis
Key Points
Non-resp sx may precede resp sx. Sx include fever, cough (+/- sputum), fatigue, anorexia, myalgia, dyspnea, sore throat, nasal congestion, diarrhea, N/V, anosmia, dysgeusia, HA, dizziness, stroke, etc. MIS-C (child, young adult): confusion/unable to awaken, severe abdo pain, cyanosis, rash, etc. Asymptomatic: ~35% overall; 16%-45% of children; ~½ of SNF pts a-/pre-symptomatic. CDC Clinician On-Call: 800-232-4636.
Choose Patient Type
Based on multiple guidelines/recommendations from specialty societies/government agencies.
Epocrates Guideline Synopsis Last Update: Sep 11, 2020
Publication Year:
2020
Source:
epocrates
Abbreviations
BMIbody mass index
BPblood pressure
CADcoronary artery disease
CKDchronic kidney disease
CRP C-reactive protein
DMdiabetes mellitus
GIgastrointestinal
HAheadache
HFheart failure
HTNhypertension
IDSAInfectious Diseases Society of America
IL-6interleukin 6
LDHlactic acid dehydrogenase
LNlymph nodes
MIS-CMultisystem Inflammatory Syndrome Children
NIHNational Institutes of Health
N/Vnausea/vomiting
PPEpersonal protective equipment
RAroom air
RR respiratory rate
SNFskilled nursing facility
SOBshortness of breath
SpO2O2 saturation by pulse oximeter
szseizure
T1DMtype 1 diabetes mellitus
T2DMtype 2 diabetes mellitus
txptransplant
WHOWorld Health Organization